| |
Borderline Personality Disorder: New Clinical Approaches
Menninger Clinic Continuing Education
Conference, Houston, Texas
March 28, 2008
|
|
|
|
|
|
|
|
Purpose of
the conference:
To present an array of
contemporary, clinical approaches
for the treatment of borderline
personality disorder. |
|
| |
|
|
| |
Conference Program |
|
| |
Welcome remarks |
|
|
|
|
John M.
Oldham, MD, MS
Senior vice president and chief of
staff, The Menninger Clinic;
professor of psychiatry and
executive vice chair, Menninger
Department of Psychiatry &
Behavioral Sciences, Baylor College
of Medicine, Houston, Texas
|
|
| |
|
|
| |
Borderline Personality Disorder:
Overview of Recent Research Findings |
|
|
|
|
Presenter:
John M. Oldham, MD, MS
Senior vice president and chief of
staff, The Menninger Clinic;
professor of psychiatry and
executive vice chair, Menninger
Department of Psychiatry &
Behavioral Sciences, Baylor College
of Medicine, Houston, Texas |
|
|
|
|
Objectives
1. Recognize current research
findings regarding the etiology and
neurobiology of borderline
personality disorder (BPD).
2. Describe evidence-based
recommendations for treatment of
patients with BPD.
3. Identify longitudinal studies of
BPD that support new ways of
categorizing and defining the
disorder, which will guide the DSM-V
planning process. |
|
|
|
|
|
|
|
Mentalizing in the Treatment of BPD |
|
|
|
|
Presenter:
Jon G. Allen, PhD
Director of psychology, The
Menninger Clinic; professor of
psychiatry and Helen Malsin Palley
Chair in Mental Health Research,
Menninger Department of Psychiatry &
Behavioral Sciences, Baylor College
of Medicine, Houston, Texas |
|
|
|
|
Objectives
1. Explain how attachment
relationships influence mentalizing
development.
2. Discuss the basic principles of
mentalizing-focused, BPD treatment. |
|
|
|
|
|
|
|
Evidence-Based Treatment of BPD |
|
|
|
|
Presenter:
Glen O. Gabbard, MD
Brown Foundation Chair of
Psychoanalysis and professor of
psychiatry, Menninger Department of
Psychiatry & Behavioral Sciences,
Baylor College of Medicine;
director, Baylor Psychiatric Clinic,
Houston, Texas |
|
|
|
|
Objectives
1. Discuss the research base for use
of medications in BPD treatment.
2. Contrast the types of
psychotherapy that have been shown
to be efficacious with patients who
have BPD. |
|
|
|
|
|
|
|
|
Family Psychoeducation for BPD |
|
|
|
|
Presenter:
Perry D. Hoffman, PhD
President, National Education
Alliance for Borderline Personality
Disorder, Rye, New York |
|
|
|
|
Objectives
1. Acknowledge the impact of BPD on
family members.
2. Identify the role of family
psychoeducation for relatives of
persons with BPD.
3. Describe specific skills to
increase family members’ coping
strategies. |
|
|
|
|
|
|
|
Borderline Personality as a
Self-Other Representational
Disturbance |
|
|
|
|
Presenter:
Donna S. Bender, PhD
Research director, Institute for
Mental Health Research, Phoenix,
Arizona; research associate
professor of psychiatry, Department
of Psychiatry, University of
Arizona, Tucson, Arizona
|
|
|
|
|
Objectives
1. Identify the role of mental
representations of self and others
in the context of BPD.
2. Consider treatment implications
of a self-other representational
model of BPD. |
|
|
|
|
|
|
|
|
New Developments in the Neurobiology
of BPD |
|
|
|
|
Presenter:
Larry J. Siever, MD
Professor of psychiatry, Department
of Psychiatry, Mount Sinai School of
Medicine, New York, New York;
director, Mental Illness Research,
Education and Clinical Center
(MIRECC), Bronx VA Medical Center,
Bronx, New York, New York |
|
|
|
|
Objectives
1. Recognize that BPDs have
neurobiologic substrates.
2. Acknowledge that these substrates
provide a rationale for
pharmacotherapy.
3. Accept that the neurobiology of
BPDs has implications for
psychosocial treatment. |
|
|
|
|
|
|
|
|
Borderline Personality Disorder in
DSM-V |
|
|
|
Presenter: Andrew E. Skodol,
MD
President, Institute for Mental
Health Research, Phoenix, Arizona;
research professor of psychiatry,
Department of Psychiatry, University
of Arizona College of Medicine,
Tucson, Arizona |
|
|
|
|
Objectives
1. Describe the goals for the DSM-V
and the process of revision.
2. Explain how BPD might be
described and diagnosed according to
alternative models being considered
for DSM-V psychiatric diagnoses. |
|
|
|
|
|
|
